BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 18370878)

  • 1. Unusual pharmacokinetics of intravitreal and systemic voriconazole in a patient with Scedosporium apiospermum endophthalmitis.
    Nochez Y; Arsene S; Le Guellec C; Bastides F; Morange V; Chaumais MC; Pisella PJ
    J Ocul Pharmacol Ther; 2008 Feb; 24(1):87-90. PubMed ID: 18370878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravitreal voriconazole for the treatment of endogenous endophthalmitis caused by Scedosporium apiospermum.
    Chen FK; Chen SD; Tay-Kearney ML
    Clin Exp Ophthalmol; 2007; 35(4):382-5. PubMed ID: 17539796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful treatment of postoperative fungal endophthalmitis using intravitreal and intracameral voriconazole.
    Lin RC; Sanduja N; Hariprasad SM
    J Ocul Pharmacol Ther; 2008 Apr; 24(2):245-8. PubMed ID: 18321199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Scedosporium apiospermum traumatic endophthalmitis successfully treated with voriconazole.
    Zarkovic A; Guest S
    Int Ophthalmol; 2007 Dec; 27(6):391-4. PubMed ID: 17901927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravitreal voriconazole for the treatment of endogenous Aspergillus endophthalmitis.
    Kramer M; Kramer MR; Blau H; Bishara J; Axer-Siegel R; Weinberger D
    Ophthalmology; 2006 Jul; 113(7):1184-6. PubMed ID: 16713628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of endogenous fungal endophthalmitis with voriconazole and caspofungin.
    Breit SM; Hariprasad SM; Mieler WF; Shah GK; Mills MD; Grand MG
    Am J Ophthalmol; 2005 Jan; 139(1):135-40. PubMed ID: 15652837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endogenous Scedosporium apiospermum endophthalmitis.
    Jain A; Egbert P; McCulley TJ; Blumenkranz MS; Moshfeghi DM
    Arch Ophthalmol; 2007 Sep; 125(9):1286-9. PubMed ID: 17846376
    [No Abstract]   [Full Text] [Related]  

  • 8. Anti-infectious activity of intravitreal injectable voriconazole microspheres on experimental rabbit fungal endophthalmitis caused by Aspergillus fumigatus.
    Xiang-Gen W; Li-Na Y; Meng X; Hao-Ran J
    J Pharm Sci; 2011 May; 100(5):1745-59. PubMed ID: 21374612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic endophthalmitis due to verticillium species after cataract surgery treated (or managed) with pars plana vitrectomy and oral and intravitreal voriconazole.
    Nehemy MB; Vasconcelos-Santos DV; Torqueti-Costa L; Magalhaes EP
    Retina; 2006 Feb; 26(2):225-7. PubMed ID: 16467684
    [No Abstract]   [Full Text] [Related]  

  • 10. Intravitreal voriconazole: in vitro safety-profile for fungal endophthalmitis.
    Kernt M; Neubauer AS; De Kaspar HM; Kampik A
    Retina; 2009 Mar; 29(3):362-70. PubMed ID: 18997637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Anti-infectious activity of intravitreal injectable voriconazole microspheres on experimental rabbit fungal endophthalmitis of Aspergillus fumigatus].
    Yang LN; Xin M; Wu XG; Jiang HR
    Yao Xue Xue Bao; 2010 Jun; 45(6):778-84. PubMed ID: 20939190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Voriconazole in fungal keratitis caused by Scedosporium apiospermum.
    Hernández Prats C; Llinares Tello F; Burgos San José A; Selva Otaolaurruchi J; Ordovás Baines JP
    Ann Pharmacother; 2004 Mar; 38(3):414-7. PubMed ID: 14755065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Favorable Outcomes of Filamentous Fungal Endophthalmitis Following Aggressive Management.
    Bui DK; Carvounis PE
    J Ocul Pharmacol Ther; 2016 Nov; 32(9):623-630. PubMed ID: 27447804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravitreal voriconazole for drug-resistant fungal endophthalmitis: case series.
    Sen P; Gopal L; Sen PR
    Retina; 2006 Oct; 26(8):935-9. PubMed ID: 17031296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of voriconazole in the surgical management of chronic postoperative fungal endophthalmitis.
    Vasconcelos-Santos DV; Nehemy MB
    Ophthalmic Surg Lasers Imaging; 2009; 40(4):425-31. PubMed ID: 19634753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anterior chamber exudative mass due to Scedosporium apiospermum in an immunocompetent individual.
    Shankar S; Biswas J; Gopal L; Bagyalakshmi R; Therese L; Borse NJ
    Indian J Ophthalmol; 2007; 55(3):226-7. PubMed ID: 17456946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Curvularia lunata endophthalmitis.
    Berbel RF; Casella AM; de Freitas D; Höfling-Lima AL
    J Ocul Pharmacol Ther; 2011 Oct; 27(5):535-7. PubMed ID: 21830946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endogenous endophthalmitis caused by Scedosporium apiospermum treated with voriconazole.
    Figueroa MS; Fortun J; Clement A; De Arévalo BF
    Retina; 2004 Apr; 24(2):319-20. PubMed ID: 15097903
    [No Abstract]   [Full Text] [Related]  

  • 19. Successful treatment of Fusarium endophthalmitis with voriconazole and Aspergillus endophthalmitis with voriconazole plus caspofungin.
    Durand ML; Kim IK; D'Amico DJ; Loewenstein JI; Tobin EH; Kieval SJ; Martin SS; Azar DT; Miller FS; Lujan BJ; Miller JW
    Am J Ophthalmol; 2005 Sep; 140(3):552-4. PubMed ID: 16139017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravitreally implantable voriconazole delivery system for experimental fungal endophthalmitis.
    Yang L; Dong X; Wu X; Xie L; Min X
    Retina; 2011 Oct; 31(9):1791-800. PubMed ID: 21606889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.